Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Nuclear Science and Technology (1)
- Advanced Manufacturing (2)
- Biology and Environment (14)
- Clean Energy (18)
- Computational Engineering (1)
- Computer Science (2)
- Energy Frontier Research Centers (1)
- Fusion and Fission (1)
- Isotopes (1)
- Materials (30)
- Materials for Computing (3)
- National Security (14)
- Neutron Science (15)
- Quantum information Science (1)
- Supercomputing (34)
Date
News Topics
- (-) Biomedical (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (2)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (1)
- Isotopes (2)
- Materials Science (1)
- Neutron Science (1)
- Nuclear Energy (7)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.